Six‐months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device‐supported patients
Sign Up to like & getrecommendations! Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.13798
Abstract: To assess the 6 months immunogenicity to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccine in a population of heart transplanted (HTx) recipients and left ventricular assist device (LVAD)‐supported patients. read more here.
Keywords: supported patients; heart transplanted; months immunogenicity; heart ... See more keywords
Radiographic case report of a heart transplanted patient suffering from COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Heliyon"
DOI: 10.1016/j.heliyon.2021.e06688
Abstract: In context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with certain comorbidities and high age, as well as male sex are considered to represent the risk group for severe course of disease. Corona-virus… read more here.
Keywords: radiographic case; heart; heart transplanted; covid ... See more keywords
Donor‐specific antibodies are associated with micro‐ and macrovascular coronary disease, restrictive myocardial damage, and poor outcome in heart‐transplanted patients
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Transplantation"
DOI: 10.1111/ctr.13033
Abstract: We examined the relationship between donor‐specific HLA antibody (DSA) presence and graft function, hemodynamics, cardiac allograft vasculopathy (CAV), and major adverse cardiac events (MACE) in stable long‐term heart‐transplanted (HTx) patients. read more here.
Keywords: associated micro; heart transplanted; specific antibodies; antibodies associated ... See more keywords
Rapid Complete Response to Single-Agent Bcl-2 Inhibitor Venetoclax in a Heart-Transplanted Patient with Triple Refractory Immunoglobulin Light-Chain Amyloidosis
Sign Up to like & getrecommendations! Published in 2020 at "Acta Haematologica"
DOI: 10.1159/000504355
Abstract: Immunoglobulin light-chain amyloidosis (AL) is a disease with limited treatment options due to the frailty of patients caused by organ damage. Since the clonal plasma cells often contain the cytogenetic aberration t(11;14), the Bcl-2 inhibitor… read more here.
Keywords: inhibitor venetoclax; chain amyloidosis; bcl inhibitor; immunoglobulin light ... See more keywords